Type |
Details |
Score |
Gene |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, African clawed |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, African clawed |
|
•
•
•
•
•
|
Publication |
First Author: |
Milne TA |
Year: |
2002 |
Journal: |
Mol Cell |
Title: |
MLL targets SET domain methyltransferase activity to Hox gene promoters. |
Volume: |
10 |
Issue: |
5 |
Pages: |
1107-17 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wilkinson AW |
Year: |
2019 |
Journal: |
Nature |
Title: |
SETD3 is an actin histidine methyltransferase that prevents primary dystocia. |
Volume: |
565 |
Issue: |
7739 |
Pages: |
372-376 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Sagai T |
Year: |
1989 |
Journal: |
Immunogenetics |
Title: |
New evidence for trans-species evolution of the H-2 class I polymorphism. |
Volume: |
30 |
Issue: |
2 |
Pages: |
89-98 |
|
•
•
•
•
•
|
Publication |
First Author: |
Marshall JD |
Year: |
1992 |
Journal: |
Mamm Genome |
Title: |
The AXB and BXA set of recombinant inbred mouse strains. |
Volume: |
3 |
Issue: |
12 |
Pages: |
669-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Petrie BF |
Year: |
1995 |
Journal: |
Psychol Rep |
Title: |
Learning set spatial navigation performance in three mouse strains. |
Volume: |
77 |
Issue: |
3 Pt 2 |
Pages: |
1339-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chawla G |
Year: |
2009 |
Journal: |
Mol Cell Biol |
Title: |
Sam68 regulates a set of alternatively spliced exons during neurogenesis. |
Volume: |
29 |
Issue: |
1 |
Pages: |
201-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Caggiano V |
Year: |
2018 |
Journal: |
Nature |
Title: |
Midbrain circuits that set locomotor speed and gait selection. |
Volume: |
553 |
Issue: |
7689 |
Pages: |
455-460 |
|
•
•
•
•
•
|
Publication |
First Author: |
Robinson FL |
Year: |
2008 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice. |
Volume: |
105 |
Issue: |
12 |
Pages: |
4916-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
SoRelle J |
Year: |
2016 |
Journal: |
MGI Direct Data Submission |
Title: |
Mutagenetix entry for set |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Yeates TO |
Year: |
2002 |
Journal: |
Cell |
Title: |
Structures of SET domain proteins: protein lysine methyltransferases make their mark. |
Volume: |
111 |
Issue: |
1 |
Pages: |
5-7 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain found in Set3 and Set4 from fungi. They contain both SET and PHD domains. In budding yeasts, Set3 forms a single complex, Set3C, with Snt1, YIL112w, Sif2, Cpr1, and two putative histone deacetylases, Hos2 and NAD-dependent Hst1. Set3C is the yeast analog of the mammalian HDAC3/SMRT complex []. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
128
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
52
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
116
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
162
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
116
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
67
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
69
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Akman B |
Year: |
2021 |
Journal: |
J Leukoc Biol |
Title: |
PRDM1 decreases sensitivity of human NK cells to IL2-induced cell expansion by directly repressing CD25 (IL2RA). |
Volume: |
109 |
Issue: |
5 |
Pages: |
901-914 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Homologous_superfamily |
Description: |
The SET domain is a 130 to 140 amino acid, evolutionary well conserved sequence motif that was initially characterised in the Drosophila proteins Su(var)3-9, Enhancer-of-zeste and Trithorax [, ]. In eukaryotic organisms, it appears in proteins with an important role in regulating chromatin-mediated gene transcriptional activation and silencing. In viruses,bacteria and archaea, its function is not clear yet []. This superfamily includes eukaryotic proteins with histone methyltransferase activity, which requires the combination of the SET domain with the adjacent cysteine-rich regions, one located N-terminally (pre-SET) and the other posterior to the SET domain (post-SET). Post- and pre- SET regions seem then to play a crucial role when it comes to substrate recognition and enzymatic activity [, ]. Other SET domain-containing proteins function as transcription factors (such as PR domain zinc finger protein 1 from humans []). The structure of the SET domain and the two adjacent regions pre-SET and post-SET have been solved [, , ]. The SET domain structure is all-β, but consists only in sets of few short strands composing no more than a couple of small sheets. Consequently the SET structure is mostly defined by turns and loops. An unusual feature is that the SET core is made up of two discontinuous segments of the primary sequence forming an approximate L-shape [, , ]. Two of the most conserved motifs in the SET domain are constituted by a stretch at the C-terminal containing a strictly conserved tyrosine residue and a preceding loop inside which the C-terminal segment passes forming a knot-like structure, but not quite a true knot. These two regions have been proven to be essential for SAM binding and catalysis, particularly the invariant tyrosine where in all likelihood catalysis takes place [, ]. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
366
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Chang B |
Year: |
2005 |
Journal: |
Vis Neurosci |
Title: |
Mouse models of ocular diseases. |
Volume: |
22 |
Issue: |
5 |
Pages: |
587-93 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
416
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1985
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Ye X |
Year: |
2016 |
Journal: |
PLoS One |
Title: |
SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis. |
Volume: |
11 |
Issue: |
1 |
Pages: |
e0146468 |
|
•
•
•
•
•
|
Publication |
First Author: |
Just S |
Year: |
2011 |
Journal: |
J Cell Sci |
Title: |
The myosin-interacting protein SMYD1 is essential for sarcomere organization. |
Volume: |
124 |
Issue: |
Pt 18 |
Pages: |
3127-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Van Aller GS |
Year: |
2016 |
Journal: |
Structure |
Title: |
Structure-Based Design of a Novel SMYD3 Inhibitor that Bridges the SAM-and MEKK2-Binding Pockets. |
Volume: |
24 |
Issue: |
5 |
Pages: |
774-781 |
|
•
•
•
•
•
|
Publication |
First Author: |
Van Aller GS |
Year: |
2012 |
Journal: |
Epigenetics |
Title: |
Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation. |
Volume: |
7 |
Issue: |
4 |
Pages: |
340-3 |
|
•
•
•
•
•
|
Publication |
First Author: |
Giakountis A |
Year: |
2017 |
Journal: |
Semin Cancer Biol |
Title: |
Smyd3-associated regulatory pathways in cancer. |
Volume: |
42 |
|
Pages: |
70-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu L |
Year: |
2009 |
Journal: |
Cancer Res |
Title: |
Identification of Smyd4 as a potential tumor suppressor gene involved in breast cancer development. |
Volume: |
69 |
Issue: |
9 |
Pages: |
4067-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fujii T |
Year: |
2016 |
Journal: |
Sci Rep |
Title: |
Smyd5 plays pivotal roles in both primitive and definitive hematopoiesis during zebrafish embryogenesis. |
Volume: |
6 |
|
Pages: |
29157 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shirai A |
Year: |
2008 |
Journal: |
J Biol Chem |
Title: |
Global analysis of gel mobility of proteins and its use in target identification. |
Volume: |
283 |
Issue: |
16 |
Pages: |
10745-52 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain of SET and MYND domain-containing protein 1 (SMYD1). SMYD1 functions as a histone methyltransferase and regulates downstream gene transcription. It methylates histone H3 at 'Lys-4' (H3K4me), seems able to perform both mono-, di-, and trimethylation. SMYD1 plays a critical role in cardiomyocyte differentiation, cardiac morphogenesis and myofibril organisation, as well as in the regulation of endothelial cells (ECs) [, ]. It is expressed in vascular endothelial cells, it has been shown that knockdown of SMYD1 in endothelial cells impairs EC migration and tube formation [].The SMYD family consists of five members including SMYD1/2/3/4/5. They contain two highly conserved structural and functional domains, the SET and MYND domains. The SET domain is involved in lysine methylation, while the MYND domain is involved in protein-protein interaction. They are essential in several mammalian developmental pathways [, , , ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain found in budding yeast Efm1 and fission yeast Set10. They are S-adenosyl-L-methionine-dependent protein-lysine N-methyltransferases. Efm1 monomethylates elongation factor 1-alpha (TEF1/TEF2) at 'Lys-30' [, ], while Set10 methylates ribosomal protein L23 (rpl23a and rpl23b) []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain of SET and MYND domain-containing protein 4 (SMYD4). SMYD4 functions as a potential tumour suppressor that plays a critical role in breast carcinogenesis at least partly through inhibiting the expression of PDGFR-alpha []. In zebrafish, SMYD4 is ubiquitously expressed in early embryos and becomes enriched in the developing heart; mutants show a strong defect in cardiomyocyte proliferation, which lead to a severe cardiac malformation [].The SMYD family consists of five members including SMYD1/2/3/4/5. They contain two highly conserved structural and functional domains, the SET and MYND domains. The SET domain is involved in lysine methylation, while the MYND domain is involved in protein-protein interaction. They are essential in several mammalian developmental pathways [, , , ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain of SET and MYND domain-containing protein 5 (SMYD5, also termed protein NN8-4AG, or retinoic acid-induced protein 15)). SMYD5 functions as a histone lysine methyltransferase that mediates H4K20me3 at heterochromatin regions []. It plays an important role in chromosome integrity by regulating heterochromatin and repressing endogenous repetitive DNA elements during differentiation []. In zebrafish embryogenesis, it plays pivotal roles in both primitive and definitive hematopoiesis [].The SMYD family consists of five members including SMYD1/2/3/4/5. They contain two highly conserved structural and functional domains, the SET and MYND domains. The SET domain is involved in lysine methylation, while the MYND domain is involved in protein-protein interaction. They are essential in several mammalian developmental pathways [, , , ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain of SET and MYND domain-containing protein 3 (SMYD3). SMYD3 functions as a histone methyltransferase that specifically methylates 'Lys-4' of histone H3, inducing di- and tri-methylation, but not monomethylation. It also methylates 'Lys-5' of histone H4 []. SMYD3 plays an important role in transcriptional activation as a member of an RNA polymerase complex []. It is overexpressed in colorectal, breast, prostate, and hepatocellular tumours, and has been implicated as an oncogene in human malignancies []. Methylation of MEKK2 by SMYD3 is important for regulation of the MEK/ERK pathway, suggesting the possibility of selectively targeting SMYD3 in RAS-driven cancers [].The SMYD family consists of five members including SMYD1/2/3/4/5. They contain two highly conserved structural and functional domains, the SET and MYND domains. The SET domain is involved in lysine methylation, while the MYND domain is involved in protein-protein interaction. They are essential in several mammalian developmental pathways [, , , ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Son J |
Year: |
2015 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Crystal structure of Legionella pneumophila type IV secretion system effector LegAS4. |
Volume: |
465 |
Issue: |
4 |
Pages: |
817-24 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain found in SETD6 and related proteins.SET domain methyltransferases can be involved both in translational and transcriptional roles. N-lysine methyltransferase SETD6 is a SET domain protein that specifically monomethylates 'Lys-310' of the RELA subunit of NF-kappa-B complex, leading to down-regulation of NF-kappa-B transcription factor activity []. Homologues in yeast monomethylate 60S ribosomal protein L42 (RPL42A and RPL42B) at 'Lys-55' [, ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
LegAS4 () is a type IV secretion system effector of Legionella pneumophila. It contains a SET domain that is involved in the modification of Lys4 of histone H3 (H3K4) in the nucleolus of the host cell, thereby enhancing heterochromatic rDNA transcription. It also contains an ankyrin repeat domain of unknown function at its C-terminal region []. This entry represents the SET domain found in LegAS4 and related proteins. |
|
•
•
•
•
•
|
Publication |
First Author: |
Berr A |
Year: |
2010 |
Journal: |
Plant Cell |
Title: |
Arabidopsis SET DOMAIN GROUP2 is required for H3K4 trimethylation and is crucial for both sporophyte and gametophyte development. |
Volume: |
22 |
Issue: |
10 |
Pages: |
3232-48 |
|
•
•
•
•
•
|
Publication |
First Author: |
Porras-Yakushi TR |
Year: |
2005 |
Journal: |
J Biol Chem |
Title: |
A novel SET domain methyltransferase modifies ribosomal protein Rpl23ab in yeast. |
Volume: |
280 |
Issue: |
41 |
Pages: |
34590-8 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
428
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
490
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain found in a group of ribulose-bisphosphate carboxylase]-lysine N-methyltransferases (RBCMTs) and related proteins from plants.In pea (Pisum sativum), the protein-lysine methyltransferase (PsLSMT, also known as RBCMT) catalyses the trimethylation of Lys-14 in the large subunit (LS) of ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco) []. Arabidopsis homologue of RBCMT, LSMT, is a protein-lysine methyltransferase methylating chloroplastic fructose 1,6-bisphosphate aldolases []. The sequence conservation pattern and structure analysis of the SET domain provides clues regarding the possible active site residues of the domain. There are three conserved sequence motifs in most of the SET domain. The N-terminal motif (I) has characteristic glycines. The central motif (II) has a distinct pattern of polar and charged residues (Asn, His). The C-terminal conserved motif (III) has a characteristic dyad of polar residues and the hydrophobic residue tyrosine. |
|
•
•
•
•
•
|
Publication |
First Author: |
Gopal S |
Year: |
2015 |
Journal: |
J Cell Biol |
Title: |
Transmembrane proteoglycans control stretch-activated channels to set cytosolic calcium levels. |
Volume: |
210 |
Issue: |
7 |
Pages: |
1199-211 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sunadome K |
Year: |
2023 |
Journal: |
Nat Commun |
Title: |
Directionality of developing skeletal muscles is set by mechanical forces. |
Volume: |
14 |
Issue: |
1 |
Pages: |
3060 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lathrop M |
Year: |
1988 |
Journal: |
Genomics |
Title: |
A mapped set of genetic markers for human chromosome 9. |
Volume: |
3 |
Issue: |
4 |
Pages: |
361-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen Z |
Year: |
2014 |
Journal: |
Nat Rev Cancer |
Title: |
Non-small-cell lung cancers: a heterogeneous set of diseases. |
Volume: |
14 |
Issue: |
8 |
Pages: |
535-46 |
|
•
•
•
•
•
|
Publication |
First Author: |
Moore SM |
Year: |
2019 |
Journal: |
Transl Psychiatry |
Title: |
Setd5 haploinsufficiency alters neuronal network connectivity and leads to autistic-like behaviors in mice. |
Volume: |
9 |
Issue: |
1 |
Pages: |
24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Firestein R |
Year: |
2002 |
Journal: |
J Clin Invest |
Title: |
Male infertility, impaired spermatogenesis, and azoospermia in mice deficient for the pseudophosphatase Sbf1. |
Volume: |
109 |
Issue: |
9 |
Pages: |
1165-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dodge JE |
Year: |
2004 |
Journal: |
Mol Cell Biol |
Title: |
Histone H3-K9 methyltransferase ESET is essential for early development. |
Volume: |
24 |
Issue: |
6 |
Pages: |
2478-86 |
|
•
•
•
•
•
|
Publication |
First Author: |
Whitlock JH |
Year: |
2023 |
Journal: |
J Cell Mol Med |
Title: |
Cell-type-specific gene expression and regulation in the cerebral cortex and kidney of atypical Setbp1(S858R) Schinzel Giedion Syndrome mice. |
Volume: |
27 |
Issue: |
22 |
Pages: |
3565-3577 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nagahama K |
Year: |
2020 |
Journal: |
Cell Rep |
Title: |
Setd1a Insufficiency in Mice Attenuates Excitatory Synaptic Function and Recapitulates Schizophrenia-Related Behavioral Abnormalities. |
Volume: |
32 |
Issue: |
11 |
Pages: |
108126 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fernandez JL |
Year: |
1989 |
Journal: |
Lab Anim |
Title: |
CBXC: a set of recombinant inbred strains between CBA/Ca and BALB/c. |
Volume: |
23 |
Issue: |
3 |
Pages: |
200-2 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saddic LA |
Year: |
2010 |
Journal: |
J Biol Chem |
Title: |
Methylation of the retinoblastoma tumor suppressor by SMYD2. |
Volume: |
285 |
Issue: |
48 |
Pages: |
37733-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ohtomo-Oda R |
Year: |
2016 |
Journal: |
Hum Pathol |
Title: |
SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas. |
Volume: |
49 |
|
Pages: |
145-55 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
The ribosomal protein L12ab (Rpl12ab) in Saccharomyces cerevisiae is modified by methylation at both arginine and lysine residues. Rkm2 (ribosomal lysine methyltransferase 2) is responsible for the predominant epsilon-trimethylation at lysine 10 of Rpl12ab [].This entry includes Rkm2 and other SET domain proteins that may also be lysine methyltransferases. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain of SET and MYND domain-containing protein 2 (SMYD2). SMYD2 functions as a histone methyltransferase that methylates both histones and non-histone proteins, including p53/TP53 and RB1 [, ]. It specifically methylates histone H3 'Lys-4' (H3K4me) and dimethylates histone H3 'Lys-36' (H3K36me2). It plays a role in myofilament organisation in both skeletal and cardiac muscles via Hsp90 methylation []. SMYD2 overexpression is associated with tumour cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas []. It regulates leukemia cell growth such that diminished SMYD2 expression upregulates SET7/9, thereby possibly shifting leukemia cells from growth to quiescence state associated with resistance to DNA damage associated with Acute Myeloid Leukemia (AML) [].The SMYD family consists of five members including SMYD1/2/3/4/5. They contain two highly conserved structural and functional domains, the SET and MYND domains. The SET domain is involved in lysine methylation, while the MYND domain is involved in protein-protein interaction. They are essential in several mammalian developmental pathways [, , , ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain found in SETD5, which is a chromatin regulator required for brain development []. SETD5 is essential for regulating histone acetylation during gene transcription []. Haploinsufficiency of SETD5 is implicated in syndromic autism spectrum disorder (ASD) []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Michurina A |
Year: |
2022 |
Journal: |
EMBO J |
Title: |
Postnatal expression of the lysine methyltransferase SETD1B is essential for learning and the regulation of neuron-enriched genes. |
Volume: |
41 |
Issue: |
1 |
Pages: |
e106459 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
The SET domain is a protein-protein interaction domain found in protein lysine methyltransferase enzymes. This entry represents a domain of unknown function which is associated with the SET domain and found in histone lysine methyltransferases []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Terranova R |
Year: |
2006 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Mll. |
Volume: |
103 |
Issue: |
17 |
Pages: |
6629-34 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
594
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain found in SETD4, which is a cytosolic and nuclear functional lysine methyltransferase that plays a crucial role in breast carcinogenesis []. However, its specific substrates and modification sites remain to be disclosed. Proteins containing this domain also include budding yeast Rkm2, which is a ribosomal protein lysine methyltransferase responsible for trimethylation of the lysine residue at position 3 of Rpl12A and Rpl12B []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain found in SETD3 and related proteins.SETD3 is a protein-histidine N-methyltransferase that specifically mediates methylation of actin at 'His-73' []. It was initially reported to have histone methyltransferase activity and methylate 'Lys-4' and 'Lys-36' of histone H3 (H3K4me and H3K36me). However, this conclusion was based on mass spectrometry data wherein mass shifts were inconsistent with a bona fide methylation event. In vitro, the protein-lysine methyltransferase activity is weak compared to the protein-histidine methyltransferase activity []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Subramanian K |
Year: |
2008 |
Journal: |
Mol Cell |
Title: |
Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. |
Volume: |
30 |
Issue: |
3 |
Pages: |
336-47 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain found in SETD7, an enzyme that specifically monomethylate Lys-4 of histone H3, thereby creating a specific tag for epigenetic transcriptional activation. Methylation of lysine residues in the N-terminal tails of histones is thought to represent an important component of the mechanism that regulates chromatin structure. SETD7 plays a central role in the transcriptional activation of genes such as collagenase and insulin. It is recruited by IPF1/PDX-1 to the insulin promoter, leading to activate transcription. SETD7 also has methyltransferase activity toward non-histone proteins, including TAF10 and p53/TP53. SETD7 monomethylates Lys-189 of TAF10, which increases the affinity of TAF10 for RNA polymerase II. SETD7 monomethylates Lys-372 of p53/TP53, which stabilises p53/TP53 and increases p53/TP53-mediated transcriptional activation [, ]. SETD7 also methylates non-histone proteins, including estrogen receptor alpha (ERa), suggesting it has a role in diverse biological processes. ERa methylation by Set7/9 stabilises ERa and activates its transcriptional activities, which are involved in the carcinogenesis of breast cancer. In a high-throughput screen, treatment of human breast cancer cells (MCF7 cells) with cyproheptadine, a Set7/9 inhibitor, decreased the expression and transcriptional activity of ERa, thereby inhibiting estrogen-dependent cell growth [, ].These enzymes contain a SET domain, which is necessary but not sufficient for histone methyltransferase activity []. Human SETD7 contains an N-terminal β-sheet domain in addition to the conserved SET domain []. Mutagenesis studies identified two residues in the C terminus of the protein that appear essential for catalytic activity toward lysine-4 of histone H3; cofactor AdoMet binds to this domain []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This entry represents histone-lysine N-methyltransferase (SETD7 or SET7/9) (), which contains a SET domain []. This enzyme specifically monomethylate Lys-4 of histone H3, thereby creating a specific tag for epigenetic transcriptional activation. Methylation of lysine residues in the N-terminal tails of histones is thought to represent an important component of the mechanism that regulates chromatin structure. As such SETD7 plays a central role in the transcriptional activation of genes such as collagenase and insulin. It is recruited by IPF1/PDX-1 to the insulin promoter, leading to activate transcription. SETD7 also has methyltransferase activity toward non-histone proteins, including TAF10 and p53/TP53. SETD7 monomethylates Lys-189 of TAF10, which increases the affinity of TAF10 for RNA polymerase II. SETD7 monomethylates Lys-372 of p53/TP53, which stabilises p53/TP53 and increases p53/TP53-mediated transcriptional activation []. These enzymes contain a SET domain, which is necessary but not sufficient for histone methyltransferase activity []. Human SETD7 contains an N-terminal β-sheet domain in addition to the conserved SET domain []. Mutagenesis studies []identified two residues in the C terminus of the protein that appear essential for catalytic activity toward lysine-4 of histone H3; cofactor AdoMet binds to this domain. |
|
•
•
•
•
•
|
Publication |
First Author: |
Diep J |
Year: |
2019 |
Journal: |
Nat Microbiol |
Title: |
Enterovirus pathogenesis requires the host methyltransferase SETD3. |
Volume: |
4 |
Issue: |
12 |
Pages: |
2523-2537 |
|
•
•
•
•
•
|
Publication |
First Author: |
Styr B |
Year: |
2019 |
Journal: |
Neuron |
Title: |
Mitochondrial Regulation of the Hippocampal Firing Rate Set Point and Seizure Susceptibility. |
Volume: |
102 |
Issue: |
5 |
Pages: |
1009-1024.e8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Baeyens N |
Year: |
2015 |
Journal: |
Elife |
Title: |
Vascular remodeling is governed by a VEGFR3-dependent fluid shear stress set point. |
Volume: |
4 |
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Leonards K |
Year: |
2020 |
Journal: |
Nat Commun |
Title: |
Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia. |
Volume: |
11 |
Issue: |
1 |
Pages: |
2807 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain found in EZH1.The Polycomb Repressive Complex 2 (PRC2) is a chromatin modifying complex that consists of three core components: EED, SUZ12 and one of the two histone H3K27 methyltransferases, EZH1 or EZH2 []. The PRC2 complex catalyses di- and trimethylation of histone H3 lysine 27 (H3K37me2/3), which has a repressive role. Even though EZH1 and EZH2 form similar PRC2 complexes, they exhibit contrasting repressive roles. In terms of their expression in mice, EZH1 is more abundant in nonproliferative adult organs, while EZH2 expression is tightly associated with proliferation []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain found in EZH2.The Polycomb Repressive Complex 2 (PRC2) is a chromatin modifying complex that consists of three core components: EED, SUZ12 and one of the two histone H3K27 methyltransferases, EZH1 or EZH2 []. The PRC2 complex catalyses di- and trimethylation of histone H3 lysine 27 (H3K37me2/3), which has a repressive role. Even though EZH1 and EZH2 form similar PRC2 complexes, they exhibit contrasting repressive roles. In terms of their expression in mice, EZH1 is more abundant in nonproliferative adult organs, while EZH2 expression is tightly associated with proliferation []. |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Rayasam GV |
Year: |
2003 |
Journal: |
EMBO J |
Title: |
NSD1 is essential for early post-implantation development and has a catalytically active SET domain. |
Volume: |
22 |
Issue: |
12 |
Pages: |
3153-63 |
|
•
•
•
•
•
|